Professors in ResidenceSenior practitioners whose direct domain experience anchors the programs.
Where the Catalyst R&D Workbench provides evidence at depth, the Professors provide judgement at the level a venture's next funder, a research program's next reviewer, or a corporate sponsor's technical due diligence team expects to see.
PS
Professor Paul Stewart
Engineering, Advanced Management & Control Systems
Vast experience in engineering and advanced management and control systems across aerospace and nuclear. For ventures whose technical claim rests on control systems, complex engineering integration, or safety-critical applications, his judgement on design realism, certification path, and operational risk is the kind of input that institutional investors and corporate sponsors typically only access through expensive specialist consultancies.
AR
Dr Alexander Reip
Materials Science & Chemistry
A highly respected materials scientist and Master of Chemistry whose direct experience covers materials development, characterisation, and the translation of laboratory chemistry into commercial process. For programs in advanced materials, novel chemistry, energy materials, and adjacent fields, his judgement on technical feasibility, scale-up risk, and IP defensibility is anchored in decades of practical work.
AP
Professor Andy Pardoe
Artificial Intelligence
One of the most publicly recognised AI voices in the UK and a well-publicised AI professional with deep experience across applied AI, AI strategy, and the public discourse around the technology. For frontier AI work, AI-enabled deep-tech, and AI in regulated or safety-critical contexts, his judgement is genuinely difficult to source elsewhere at the same level.
AB
Dr Aqib Bhatti
Clinical Medicine & Healthcare Systems
Considerable experience as a practising General Physician and Medical Director for one of the largest service providers to the NHS. For health-tech, medical-device, digital-health, and clinical-software programs, his judgement covers both clinical realism and the operational reality of NHS-scale healthcare delivery - including procurement, integration with existing care pathways, regulatory expectations, and the practical economics of clinical adoption.
MM
Mel Morris CBE
Entrepreneurship, Capital & the Investor Network
Eight successful business exits valued in total at more than $7Bn. Within Corpora.ai's programs - and in addition to his role as co-founder of the company - Mel provides direct entrepreneurial mentorship, pre-seed capital to selected ventures through Crucible, and the onward referral network into a curated set of partner venture capital firms for follow-on funding.
